Cost, effectiveness and incremental cost-effectiveness ratio (ICER) for the base case and two time horizons in males
| Horizon | Cost | Effectiveness QALY | ICER ·QALY−1 | ||
| No treatment | nCPAP | No treatment | nCPAP | ||
| 5 yrs | 55 | 2719 | 3.39 | 3.73 | 7861 |
| Lifespan | 591 | 7902 | 12.90 | 14.38 | 4938 |
Data are means. : Euro
QALY: quality-adjusted life year
nCPAP: nasal continuous positive airway pressure